DAFTAR PUSTAKA

1.
2.

3.
4.
5.

6.
7.

8.
9.

10.

11.
12.
13.
14.
15.

16.
17.
18.

Langley R, Krueger G, Griffiths C. Psoriasis: Epidemiology, clinical features,

and quality of life. Ann Rheum Dis 2005:64(Suplemen II):ii18-23.
Gudjonsson JE, Elder JT. Psoriasis. Dalam: Wolff K, Goldsmith LA, Katz SI,
Gilchrest BA, Paller AS, Leffell DJ, penyunting. Fitzpatricks Dermatology
in General Medicine. Edisi ke-7. New York. McGraw-Hill; 2008:169-93
Jones JB. Psoriasis. Medicine 2009;37(5):235-41
Voorhees AS, Fried R. Depression and quality of life in psoriasis.
Postgraduate Medicine 2009;121:154-61
Ghajarzadeh M, Kheirkhan S, Ghiasi M, Hoseini N. Depression and Quality
of life in psoriasis and psoriatic arthritis patients. Irianian Journal of
Dermatology 2011;14:123-8
Gudjonsson JE, Elder JT. Psoriasis : Epidemiology. Clinic in dermatology
2007;25:535-46
Jacoeb TNA, Psoriasis Gambaran klinis dan Penilaian Keparahan. Dalam:
Tjarta A, Sularsito A, Kurniati DD, Rihatmaja R, penyunting. Metode
Diagnostik dan Penatalaksanaan Psoriasis dan Dermatitis Seboroik. Jakarta.
FK UI. 2003: 1-13.
Rakhesh S.V, DSouza M, Sahai A. Quality of life in psoriasis: A study from
south India. Indian J Dermatol Venereol Leprol 2008;74:600-6.
Potocka A,Turczyn-Jablonska K, Merecz D. Psychological correlates of
quality of life in dermatology patients: the role of mental health and selfacceptance: Acta Dermatoven APA 2009; 18(2):53-62.
Wibowo B. Hubungan Kepositivan Autologus Serum Skin Test dengan
gambaran Klinik dan Kualitas Hidup pada Penderita Urtikaria Kronik.
Semarang:Fakultas Kedokteran Universitas Diponegoro 2006; 1-20
Finlay AY, Kelly SE. Psoriasis on Index of Disability. Clin Exp. Dermatol
1987;12:8-11
Finlay AY Coles EC. The Effect of Severity Psoriasis on the Quality of Life
of 369 Patients . Br J Dermatol 1995;132:236-44.
Feldman SR, Rapp SR. Quality of life Dalam: Gordon KB, Ruderman EN.
Psoriasis and Psoriatic arthritis. Heidelberg: Spinger. 2005;110-7
Bhosle MJ, Kurkarni A, Feldman SR, Balkrishnan R. Quality of life in
patiens with psoriasis. Health and Quality of life outcomes 2006;4:1-7
Cotterill JA, Finlay AY. General aspects of Treatment. Dalam: BurnsT,
Breathnach SM, Cox N, Griffiths C, penyunting. Rooks Textbook of
Dermatology. Edisi ke-7. London: Blackwell Science. 2004; 71.1-23
Budiastuti A, Sugianto R. Hubungan Umur dan Lama Sakit terhadap Derajat
Keparahan Penderita Psoriasis. M Med Indones 2009;43(6):312-16.
Sugianto YFR, Erdina HDP, Tjut NAJ, Oki S. Simposium Practical
Management of Psoriasis. 2011 Okt 29; Jakarta;2011
Coimbra S, Oliveira H, Figueiredo A, pereira PR, Silva AS. Psoriasis:
Epidemiology, Clinical and Histological Features, Triggering Factors,
Assessments of Severity and Psychosocial Aspects.Intechopen. 2004; 3:69-82

Universitas Sumatera Utara

19. Schmitt J, Wozel G : The Psoriasis Area and Severity Index Is the Adequate
Criterion to Dene Severity in Chronic Plaque- Type Psoriasis. Dermatology
2005;210:194-9
20. Schmid-Ott G, Steeen T. Skin Disorders and Quality of Life. Diunduh dari
http://www: Cirrie.boffalo.edo/encyclopedia/en/articel/152 diakses tanggal 10
Maret 2012
21. Rapp SK, Feldman SK, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis
causes as much Disability as other Major Medical Diseases. Journal of the
American Academy of Dermatology 1999;41:400-7
22. Krueger G, Koo J, Lebwohl M, Manter A, Stern RS, Rolstad T. The Impact
of Psoriasis on Quality of Life. Results of a 1998 National Psoriasis
Foundation Patient-Membership Survey. Arch Dermatol. 2010;137(3):280-4.
23. Schmid-Ott G, Malewski P, Kreiselmaier I, Mrowietz U. Psychosocial
Consequences of Psoriasis-an Emperical Study of Diseases Burden in 3753
affected People. Hautarzt 2005b;56:466-72
24. Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, Feldman SR.
The Negative Impact of Psoriasis on the Workplace. J Dermatolog Treat.
2006;17(1):24-8.
25. Gupta MA, Gupta AK. Psychodermatology: An Update. Journal of the
American Academy of Dermatology 1996;34:1030-46
26. Schmitt JM, Ford DE. Role of Depression in Quality of Life for Patients with
Psoriasis. Dermatology 2007;215:17-27.
27. Picardi A, Mazzotti E, Pasquini P. Prevalence and Correlates of suicidal
Ideation among Patients with Skin Disease. Journal of the American
Academy of Dermatology 2006;54:420-26.
28. Lin TY, See LC, Shen YM, Liang YC, Chang NH, Lin KY. Quality of life in
patients with Psoriasis in Northern Taiwan. Chang Gung Medical Journal
2011;34:186-96
29. Camisa C.Pathogenesis of psoriasis. Dalam : Camisa C, Penyunting.
Handbook of Psoriasis. Edisi ke-2.London. Blackwell Publishing;2004:45-60
30. Azzizadeh M, Malek M, Amiri M. Does prolactin indicate severity of
psoriasis?. Iranian journal of dermatology 2009;12(III): 47-51
31. Dilme E, Martin G, Regana M. Serum prolactin levels in psoriasis and
correlation with cutaneous disease activity. Clinical and experimental
dermatology 2010;36:29-32
32. Feldman S, Krueger G. Psoriasis assesment tools in clinical trial. An Rheum.
Dis.2005;64(II):65-8
33. Kenneth B. Clinical outcome measurements. Psoriasis and Psoriatic Arthritsan integrated Approach. Edisi ke-1. New York. Springer;2005:125-8
34. Bonifati C, Berardesca E. Clinical outcome measures of psoriasis.
Reumatismo 2007;59( 1):64-7
35. Sadick NS. The Impact of Cosmetic Interventions on Quality of life
Dermatology on line Journal 2008;14(8):2
36. Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology
Life Quality Index 1994-2007: A Comprehensive Review of Validation Data
and Clinical Results. The British Journal of Dermatology. 2008;159(5):9971035

Universitas Sumatera Utara

37. Torres RAT, Magalhaes RF, Velho PEN, Silvia SA, Morcillo AM.
Comparation of Quality of Life Questionners and their Correlation with the
Clinical Course of Patients with Psoriasis. An Bras Dermatol 2011;86(1);45-9
38. Davidson S, Blomqvist K, Molin L, Mork C, Sigurgeirsson B, Zachariae H,
Zachariae R. Lifestyle of Nordic with Psoriasis. International Journal of
Dermatology 2005;44:378-83
39. Hongbo Y, Thomas CL, Harisson MA, Salek Ms, Finlay AY. Translating the
Science of Quality of Life into Practice: What do Dermatology Life Quality
Index Scor Mean? Journal of Investigative Dermatology 2009;125:659-64
40. Finlay AY. Curent severe psoriasis and the rule of ten.The british Journal of
Dermatology.2005;152(5):861-7.
41. Krueger GG, Feldman SR, Camisa C et al. Two Consideration for Patients
with Psoriasis and Their Clinicians: What Defines Mild, Moderateand Severe
Psorisis? What Constituted a Clinically Significant Improvement when
Treating Psoriasis. J AM Acad Dermatol 2000;43:281-5.
42. Solovan CS, Mihaescu VO. Biologycal therapies and the quality of life issue
in psoriasis. Dalam Medica a Journal of Clinical Medicine. 2008:3(1):40-4
43. Katugampola RP, Lewis VJ, Finlay AY. The Dermatology Life Quality
Index: the efficacy of biological therapies for psoriasis. BMJ. 2007;156:94550
44. Prins M, Krabbbe PFM, Swinkels QOJ.The Effect of Treatment on Quality of
Life in Psoriasis Patients. Acta Derm Venereol.2005;85:304-10.
45. Dogra S, Yadav S. Psoriasis in India: Prevalence and Pattern. Indiana J
Dermatol Venereol Leprol.2010;76:595-601
46. Sinniah B, Devi S, Prashant D. Epidemiology of Psoriasis in Malaysia: A
Hospital Based Study. Med J Malaysia 2010; 65(2):112-14
47. Richardson SK, Gelfand JM. Update on the Natural History and Systemic
Treatment of Psorisis. Advances in Dermatology. Elsevier.2008 (21):171-96.
48. Neimann Al, Porter SB, Gelfand JM. The Epidemiology of Psoriasis. Expert
Rev. Dermatol.2006(1):63-75.
49. Gelfand JM, Weistein R, Porter SB, Neimann AL, Berlin JA Margolis DJ.
Prevalence and Treatment of Psoriasis in the United Kingdom. Arch
Dermatol 2005;141-53.
50. Chang Y, Chen T, Liu P, Chen Y, Huang Y. Epidemiological Study of
Psoriasis in the National Health Insurance Database in Taiwan. Acta Derm
Venereol. 2009;89:262-66.
51. Gupta MA, Gupta AK. Depression and Suicidal Ideation in Dermatology
Patients with Acne, Alopecia areata, Atopic dermatitis and Psoriasis. British
Journal of Dermatology 1998;139:846-50.
52. Kurd SK, Andra BT, Paul CC, Joel MG. The Risk Of depresion, Anxiety and
Suicidality in Patients with Psoriasis: A Population-based Cohort Study.
NIHPA Author Manuscripts 2010:891-5
53. Gupta MA, Gupta AK. Age and Gender Differences in the Impact of
Psoriasis on Quality of Life. International Journal of Dermatology
1995;34(10):700-3
54. Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-Life Effect of
Common Dermatological Diseases. Frontline Medical Communications
2013;101-8

Universitas Sumatera Utara

55. Polat M, Yalcin B, Alli N. Perspective of Psoriasis in Turkey, Dermatologica

Sinica 2012;7-10.
56. Galkwed R, Deshpande S, Raje S, Dhamdhere. Evaluation of Functional
Impairment in Psoriasis. Indiana J Dermatol Venereol Leprol 2006;72:37-40.
57. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Association between Skin Diseases
and Quality of Life. A Comparison of Psoriasis, Vitiligo, and Alopecia
Areata. Acta Medica Iranica, 2012;50(7):511-4

Universitas Sumatera Utara